Interestingly, although Lys-219 of human PrP slows or modifies pathologies of sporadic CJD (28, 29, 31, 42), new-variant CJD might not be affected or even be enhanced (43, 44). This evidence concerns the gene PRNP and Creutzfeldt Jacob disease.